Các bài viết có thể truy cập công khai - LeAnn B. Norris, PharmD, FHOPA, FCCP, BCPS, BCOPTìm hiểu thêm
Không có ở bất kỳ nơi nào: 2
Generic oncology drugs: are they all safe?
YT Yang, S Nagai, BK Chen, ZP Qureshi, AA Lebby, S Kessler, ...
The lancet oncology 17 (11), e493-e501, 2016
Các cơ quan ủy nhiệm: US National Institutes of Health
Investigating Serious Adverse Drug Reactions in Patients Receiving Erythropoiesis-Stimulating Agents: A Root Cause Analysis Using the “ANTICIPATE” Framework
S Jacob, J Nichols, IC Macdougall, Z Qureshi, B Chen, YT Yang, ...
American Journal of Therapeutics 25 (6), e670-e674, 2018
Các cơ quan ủy nhiệm: US National Institutes of Health
Có tại một số nơi: 17
Colony-stimulating factors for febrile neutropenia during cancer therapy
CL Bennett, B Djulbegovic, LAB Norris, JO Armitage
New England Journal of Medicine 368 (12), 1131-1139, 2013
Các cơ quan ủy nhiệm: US National Institutes of Health
Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project
KR Carson, SD Newsome, EJ Kim, ND Wagner‐Johnston, G Von Geldern, ...
Cancer 120 (16), 2464-2471, 2014
Các cơ quan ủy nhiệm: US National Institutes of Health
Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease
CL Bennett, ZP Qureshi, AO Sartor, LAB Norris, A Murday, S Xirasagar, ...
Clinical kidney journal 5 (1), 82-88, 2012
Các cơ quan ủy nhiệm: US National Institutes of Health
Hepatitis B virus reactivation: risk factors and current management strategies
DJ Smalls, RE Kiger, LAB Norris, CL Bennett, BL Love
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (12 …, 2019
Các cơ quan ủy nhiệm: US National Institutes of Health
A review of safety, efficacy, and utilization of erythropoietin, darbepoetin, and peginesatide for patients with cancer or chronic kidney disease: a report from the Southern …
CL Bennett, DM Spiegel, IC Macdougall, LA Norris, ZP Qureshi, O Sartor, ...
Seminars in thrombosis and hemostasis 38 (08), 783-796, 2012
Các cơ quan ủy nhiệm: US National Institutes of Health
Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye’s syndrome. a report from the Southern Network on Adverse …
CL Bennett, KM Starko, HS Thomsen, S Cowper, O Sartor, IC Macdougall, ...
Journal of general internal medicine 27, 1697-1703, 2012
Các cơ quan ủy nhiệm: US National Institutes of Health
Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR)
RA Sabol, V Noxon, O Sartor, JR Berger, Z Qureshi, DW Raisch, ...
Cancer medicine 6 (7), 1541-1551, 2017
Các cơ quan ủy nhiệm: US National Institutes of Health
Regulatory and clinical experiences with biosimilar filgrastim in the US, the European Union, Japan, and Canada
B Chen, S Nagai, JO Armitage, B Witherspoon, C Nabhan, AC Godwin, ...
The oncologist 24 (4), 537-548, 2019
Các cơ quan ủy nhiệm: US National Institutes of Health
Caveat oncologist: clinical findings and consequences of distributing counterfeit erythropoietin in the United States
ZP Qureshi, LA Norris, O Sartor, JM McKoy, J Armstrong, DW Raisch, ...
Journal of oncology practice 8 (2), 84-90, 2012
Các cơ quan ủy nhiệm: US National Institutes of Health
Progressive multi‐focal leucoencephalopathy among ibrutinib‐treated persons with chronic lymphocytic leukaemia.
CL Bennett, JR Berger, O Sartor, KR Carson, WJ Hrushesky, ...
British Journal of Haematology 180 (2), 2018
Các cơ quan ủy nhiệm: US National Institutes of Health
Effects of the US Food and Drug Administration boxed warning of erythropoietin-stimulating agents on utilization and adverse outcome
J Bian, B Chen, DL Hershman, N Marks, LA Norris, R Schulz, CL Bennett
Journal of Clinical Oncology 35 (17), 1945-1951, 2017
Các cơ quan ủy nhiệm: US National Institutes of Health
Tale of two erythropoiesis-stimulating agents: utilization, dosing, litigation, and costs of darbepoetin and epoetin among South Carolina Medicaid-covered patients with cancer …
V Noxon, KB Knopf, LAB Norris, B Chen, YT Yang, ZP Qureshi, ...
Journal of oncology practice 13 (6), e562-e573, 2017
Các cơ quan ủy nhiệm: US National Institutes of Health
Major hemorrhage in chronic lymphocytic leukemia patients in the US Veterans Health Administration system in the pre‐ibrutinib era: Incidence and risk factors
P Georgantopoulos, H Yang, LAB Norris, CL Bennett
Cancer medicine 8 (5), 2233-2240, 2019
Các cơ quan ủy nhiệm: US National Institutes of Health
Emerging drugs for treatment of anemia of chronic kidney disease
JS Magwood, A Lebby, B Chen, S Kessler, LA Norris, CL Bennett
Expert Opinion on Emerging Drugs 18 (4), 421-429, 2013
Các cơ quan ủy nhiệm: US National Institutes of Health
Primary prophylaxis with hematopoietic colony stimulating factor: insights from a canadian cost-effectiveness analysis
SA Strassels, M Dickson, LAB Norris, CL Bennett
Journal of the National Cancer Institute 105 (15), 1072-1073, 2013
Các cơ quan ủy nhiệm: US National Institutes of Health
A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions—a SONAR report
B Chen, J Restaino, LA Norris, S Xirasagar, ZP Qureshi, JM McKoy, ...
Journal of oncology practice 8 (6), e158-e167, 2012
Các cơ quan ủy nhiệm: US National Institutes of Health
Conflicts Of Interest In Pharmaceutical Sponsored Research On Erythropoietin Receptors In Cancer: An Updated Analysis
A Trenery, S Kessler, A Lebby, CL Bennett, P Yarnold, P Ray, DW Raisch, ...
Blood 122 (21), 2938, 2013
Các cơ quan ủy nhiệm: US National Institutes of Health
Chương trình máy tính sẽ tự động xác định thông tin xuất bản và thông tin về nhà tài trợ